Xylem Inc. XYL
Set alert
96.60 USD -0.66 -0.68%
As of Nov 3, 11:28 AM ET
95.01 Day range 97.26
88.23 52-week range 151.31
- YTD
- -29.06%
- 1 year
- -35.21%
- Open
- 97.21
- Prev close
- 97.26
- Mkt cap
- 22.15B
- Vol
- 371.74K
- Avg vol
- 2.54M
- EPS
- 4.51
- P/E
- 21.42
- Div yield
- 1.90%
More statistics
- Low
- 95.01
- High
- 97.26
- Forward P/E
- 16.43
- Beta
- 0.99
- Short ratio
- 4.28
- Inst. own
- 99.78%
- Dividend
- 1.72
- Ex-div date
- Aug 26, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 105.03
- 200-d avg
- 117.30
- 1y target
- 127.69
5D chart
Events in this range
- Oct 28, 2026Rating: Stifel · Buy → Buy
- Oct 28, 2026Rating: Goldman Sachs · Buy → Buy
- Oct 28, 2026Rating: BNP Paribas · Outperform → Outperform
- Oct 28, 2026Rating: Citigroup · Buy → Buy
- Oct 29, 2026Downgrade: Barclays · Overweight → Equal-Weight
- Oct 29, 2026Rating: UBS · Neutral → Neutral
Signals (116)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 11:15 AM | 13 minutes ago |
| SMA: Bullish | Nov 3, 11:10 AM | 18 minutes ago |
| SMA: Bullish | Nov 3, 11:05 AM | 23 minutes ago |
| SMA: Bearish | Nov 3, 11:00 AM | 28 minutes ago |
| SMA: Bearish | Nov 3, 11:00 AM | 28 minutes ago |
| SMA: Bullish | Nov 3, 10:30 AM | 58 minutes ago |
| MACD: Buy Signal | Nov 3, 10:20 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 10:05 AM | 1 hour ago |
| RSI: Oversold | Nov 3, 9:35 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bullish | Nov 2, 3:55 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:40 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:40 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:40 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:30 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 21 hours ago |
Newest 20 of 116.
Analyst view
Consensus: buy
Buy
Price target (mean) 127.69 +32.2% upside
Now 96.60
- Target (low)
- 90.00
- Target (mean)
- 127.69
- Target (high)
- 180.00
Ratings (0m) 21 13 buy · 7 hold · 1 sell
- Strong buy3
- Buy10
- Hold7
- Sell0
- Strong sell1
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.42 | 1.34 – 1.46 | 1.42 | +0.1% | 2.29B | -4.6% | 15 |
| Next quarter | 1.15 | 1.05 – 1.22 | 1.12 | +3.1% | 2.13B | +0.3% | 14 |
| Current year | 5.43 | 5.35 – 5.45 | 5.08 | +6.9% | 8.95B | -0.9% | 16 |
| Next year | 5.92 | 5.44 – 6.46 | 5.43 | +9.1% | 9.31B | +4.0% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 28, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 28, 2026 | BNP Paribas | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 28, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 28, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 28, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
| Oct 19, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 15, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Oct 14, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Oct 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 24, 2026 | Jefferies | Maintained | Buy | Buy |
| Aug 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 29, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 29, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jul 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 16, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 25, 2026 | Jefferies | Upgrade | Hold | Buy |
| Apr 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 29, 2026 | Oppenheimer | Maintained | Outperform | Outperform |